These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 19179201)

  • 1. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
    Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
    J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
    Kioka H; Yamada T; Mine T; Morita T; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Hori M; Fukunami M
    Heart; 2007 Oct; 93(10):1213-8. PubMed ID: 17344327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cardiac meta-iodobenzylguanidine imaging to identify patients with chronic heart failure and left ventricular ejection fraction <35% at low risk for sudden cardiac death.
    Kawai T; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Am J Cardiol; 2015 Jun; 115(11):1549-54. PubMed ID: 25851796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
    Kuramoto Y; Yamada T; Tamaki S; Okuyama Y; Morita T; Furukawa Y; Tanaka K; Iwasaki Y; Yasui T; Ueda H; Okada T; Kawasaki M; Levy WC; Komuro I; Fukunami M
    Am J Cardiol; 2011 Apr; 107(8):1185-90. PubMed ID: 21349482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of Cardiac MetaIodobenzylguanidine Imaging to Improve Prognostic Power of the Model for End-Stage Liver Disease Scoring System in Patients With Mild-to-Moderate Chronic Heart Failure.
    Hakui H; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Ishimi M; Sato Y; Seo M; Ozaki T; Ikeda I; Fukuhara E; Sakata Y; Fukunami M
    Am J Cardiol; 2016 Jun; 117(12):1947-52. PubMed ID: 27237625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Heart; 2011 Jan; 97(1):20-6. PubMed ID: 21062772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Anastasiou-Nana MI; Terrovitis JV; Athanasoulis T; Karaloizos L; Geramoutsos A; Pappa L; Tsagalou EP; Efentakis S; Nanas JN
    Am J Cardiol; 2005 Aug; 96(3):427-31. PubMed ID: 16054475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
    Matsunari I; Aoki H; Nomura Y; Takeda N; Chen WP; Taki J; Nakajima K; Nekolla SG; Kinuya S; Kajinami K
    Circ Cardiovasc Imaging; 2010 Sep; 3(5):595-603. PubMed ID: 20534790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
    Momose M; Okayama D; Nagamatsu H; Kondo C; Hagiwara N; Sakai S
    Ann Nucl Med; 2011 Jul; 25(6):419-24. PubMed ID: 21461599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion.
    Pedretti RF; Catalano O; Ballardini L; de Bono DP; Radice E; Tramarin R
    Int J Cardiol; 1999 Jan; 68(1):83-93. PubMed ID: 10077405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of sudden cardiac death in patients with chronic heart failure by regional washout rate in cardiac MIBG SPECT imaging.
    Yamamoto H; Yamada T; Tamaki S; Morita T; Furukawa Y; Iwasaki Y; Kawasaki M; Kikuchi A; Kondo T; Ozaki T; Seo M; Sato Y; Ikeda I; Fukuhara E; Abe M; Nakamura J; Fukunami M
    J Nucl Cardiol; 2019 Feb; 26(1):109-117. PubMed ID: 28500540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
    Imamura Y; Fukuyama T
    Ann Nucl Med; 2002 Sep; 16(6):387-93. PubMed ID: 12416577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M; Forleo C; Guida P; Romito R; Sorgente A; Sorrentino S; Catucci S; Mastropasqua F; Pitzalis M
    J Am Coll Cardiol; 2007 Jul; 50(3):225-31. PubMed ID: 17631214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure.
    Miranda SM; Moscavitch SD; Carestiato LR; Felix RM; Rodrigues RC; Messias LR; Azevedo JC; Nóbrega AC; Mesquita ET; Mesquita CT
    Arq Bras Cardiol; 2013 Jul; 101(1):4-8. PubMed ID: 23917506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.